No Data
Neptune Biotech: Report for the third quarter of 2024
Neptune Biotech: 2024 Semi-Annual Report Summary
Neptune Biology: 2024 Semi-Annual Report
Shenzhen Neptunus Bioengineering (000078.SZ): the net income in the first half of the year was 45.4098 million yuan, a decrease of 48.21% year-on-year.
Shenzhen Neptunus Bioengineering (000078.SZ) announced its semi-annual report for 2024, with a total operating income of 16.631 billion yuan, a decrease of 16.65% year-on-year; net income attributable to shareholders of the listed company was 45.4098 million yuan, a decrease of 48.21% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 38.9017 million yuan, a decrease of 28.11% year-on-year; basic earnings per share was 0.0173 yuan.
Express News | Shenzhen Neptunus Bioengineering: Net income in the first half of 2024 decreased by 48.21% compared to the same period last year.
After two and a half years of planning, Shenzhen Neptunus Bioengineering will be acquired by Guangdong State-owned Assets.
Shenzhen Neptunus Bioengineering's leveraged expansion has led to significant debt pressure, resulting in a total loss of over 2.7 billion yuan in 2022 and 2023.
No Data
No Data